304 related articles for article (PubMed ID: 25024217)
1. The tumor necrosis factor alpha-induced protein 3 (TNFAIP3, A20) imposes a brake on antitumor activity of CD8 T cells.
Giordano M; Roncagalli R; Bourdely P; Chasson L; Buferne M; Yamasaki S; Beyaert R; van Loo G; Auphan-Anezin N; Schmitt-Verhulst AM; Verdeil G
Proc Natl Acad Sci U S A; 2014 Jul; 111(30):11115-20. PubMed ID: 25024217
[TBL] [Abstract][Full Text] [Related]
2. Keratinocyte-specific ablation of the NF-κB regulatory protein A20 (TNFAIP3) reveals a role in the control of epidermal homeostasis.
Lippens S; Lefebvre S; Gilbert B; Sze M; Devos M; Verhelst K; Vereecke L; Mc Guire C; Guérin C; Vandenabeele P; Pasparakis M; Mikkola ML; Beyaert R; Declercq W; van Loo G
Cell Death Differ; 2011 Dec; 18(12):1845-53. PubMed ID: 21566665
[TBL] [Abstract][Full Text] [Related]
3. B cells lacking the tumor suppressor TNFAIP3/A20 display impaired differentiation and hyperactivation and cause inflammation and autoimmunity in aged mice.
Chu Y; Vahl JC; Kumar D; Heger K; Bertossi A; Wójtowicz E; Soberon V; Schenten D; Mack B; Reutelshöfer M; Beyaert R; Amann K; van Loo G; Schmidt-Supprian M
Blood; 2011 Feb; 117(7):2227-36. PubMed ID: 21088135
[TBL] [Abstract][Full Text] [Related]
4. Vitamin E γ-Tocotrienol Inhibits Cytokine-Stimulated NF-κB Activation by Induction of Anti-Inflammatory A20 via Stress Adaptive Response Due to Modulation of Sphingolipids.
Wang Y; Park NY; Jang Y; Ma A; Jiang Q
J Immunol; 2015 Jul; 195(1):126-33. PubMed ID: 26002975
[TBL] [Abstract][Full Text] [Related]
5. The kinase IKKα inhibits activation of the transcription factor NF-κB by phosphorylating the regulatory molecule TAX1BP1.
Shembade N; Pujari R; Harhaj NS; Abbott DW; Harhaj EW
Nat Immunol; 2011 Jul; 12(9):834-43. PubMed ID: 21765415
[TBL] [Abstract][Full Text] [Related]
6. DNGR1-mediated deletion of A20/Tnfaip3 in dendritic cells alters T and B-cell homeostasis and promotes autoimmune liver pathology.
Das T; Bergen IM; Koudstaal T; van Hulst JAC; van Loo G; Boonstra A; Vanwolleghem T; Leung PSC; Gershwin ME; Hendriks RW; Kool M
J Autoimmun; 2019 Aug; 102():167-178. PubMed ID: 31151831
[TBL] [Abstract][Full Text] [Related]
7. A20/Tumor Necrosis Factor α-Induced Protein 3 in Immune Cells Controls Development of Autoinflammation and Autoimmunity: Lessons from Mouse Models.
Das T; Chen Z; Hendriks RW; Kool M
Front Immunol; 2018; 9():104. PubMed ID: 29515565
[TBL] [Abstract][Full Text] [Related]
8. The ubiquitin modifying enzyme A20 restricts B cell survival and prevents autoimmunity.
Tavares RM; Turer EE; Liu CL; Advincula R; Scapini P; Rhee L; Barrera J; Lowell CA; Utz PJ; Malynn BA; Ma A
Immunity; 2010 Aug; 33(2):181-91. PubMed ID: 20705491
[TBL] [Abstract][Full Text] [Related]
9. Spontaneous NF-κB activation by autocrine TNFα signaling: a computational analysis.
Pękalski J; Zuk PJ; Kochańczyk M; Junkin M; Kellogg R; Tay S; Lipniacki T
PLoS One; 2013; 8(11):e78887. PubMed ID: 24324544
[TBL] [Abstract][Full Text] [Related]
10. A20 deficiency in B cells enhances B-cell proliferation and results in the development of autoantibodies.
Hövelmeyer N; Reissig S; Xuan NT; Adams-Quack P; Lukas D; Nikolaev A; Schlüter D; Waisman A
Eur J Immunol; 2011 Mar; 41(3):595-601. PubMed ID: 21341261
[TBL] [Abstract][Full Text] [Related]
11. A20 (TNFAIP3) deficiency in myeloid cells triggers erosive polyarthritis resembling rheumatoid arthritis.
Matmati M; Jacques P; Maelfait J; Verheugen E; Kool M; Sze M; Geboes L; Louagie E; Mc Guire C; Vereecke L; Chu Y; Boon L; Staelens S; Matthys P; Lambrecht BN; Schmidt-Supprian M; Pasparakis M; Elewaut D; Beyaert R; van Loo G
Nat Genet; 2011 Aug; 43(9):908-12. PubMed ID: 21841782
[TBL] [Abstract][Full Text] [Related]
12. [Immune regulation role of A20 and its clinical significance].
Li YQ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Aug; 19(4):851-6. PubMed ID: 21867600
[TBL] [Abstract][Full Text] [Related]
13. Mycobacterium fortuitum induces A20 expression that impairs macrophage inflammatory responses.
Lee GJ; Lee HM; Kim TS; Kim JK; Sohn KM; Jo EK
Pathog Dis; 2016 Apr; 74(3):. PubMed ID: 26940588
[TBL] [Abstract][Full Text] [Related]
14. A20 (TNFAIP3) alleviates CVB3-induced myocarditis via inhibiting NF-κB signaling.
Gui J; Yue Y; Chen R; Xu W; Xiong S
PLoS One; 2012; 7(9):e46515. PubMed ID: 23029542
[TBL] [Abstract][Full Text] [Related]
15. Deubiquitinating enzyme A20 negatively regulates NF-κB signaling in skeletal muscle in mdx mice.
Charan RA; Hanson R; Clemens PR
FASEB J; 2012 Feb; 26(2):587-95. PubMed ID: 22012122
[TBL] [Abstract][Full Text] [Related]
16. The ubiquitin-editing protein A20 prevents dendritic cell activation, recognition of apoptotic cells, and systemic autoimmunity.
Kool M; van Loo G; Waelput W; De Prijck S; Muskens F; Sze M; van Praet J; Branco-Madeira F; Janssens S; Reizis B; Elewaut D; Beyaert R; Hammad H; Lambrecht BN
Immunity; 2011 Jul; 35(1):82-96. PubMed ID: 21723156
[TBL] [Abstract][Full Text] [Related]
17. The zinc finger protein A20 inhibits TNF-induced NF-kappaB-dependent gene expression by interfering with an RIP- or TRAF2-mediated transactivation signal and directly binds to a novel NF-kappaB-inhibiting protein ABIN.
Heyninck K; De Valck D; Vanden Berghe W; Van Criekinge W; Contreras R; Fiers W; Haegeman G; Beyaert R
J Cell Biol; 1999 Jun; 145(7):1471-82. PubMed ID: 10385526
[TBL] [Abstract][Full Text] [Related]
18. Tumor necrosis factor gene-engineered J558 tumor cell-released exosomes stimulate tumor antigen P1A-specific CD8+ CTL responses and antitumor immunity.
Xie Y; Bai O; Zhang H; Li W; Xiang J
Cancer Biother Radiopharm; 2010 Feb; 25(1):21-8. PubMed ID: 20187793
[TBL] [Abstract][Full Text] [Related]
19. Frequent inactivation of A20 in B-cell lymphomas.
Kato M; Sanada M; Kato I; Sato Y; Takita J; Takeuchi K; Niwa A; Chen Y; Nakazaki K; Nomoto J; Asakura Y; Muto S; Tamura A; Iio M; Akatsuka Y; Hayashi Y; Mori H; Igarashi T; Kurokawa M; Chiba S; Mori S; Ishikawa Y; Okamoto K; Tobinai K; Nakagama H; Nakahata T; Yoshino T; Kobayashi Y; Ogawa S
Nature; 2009 Jun; 459(7247):712-6. PubMed ID: 19412163
[TBL] [Abstract][Full Text] [Related]
20. Upregulation of Tim-3 and PD-1 expression is associated with tumor antigen-specific CD8+ T cell dysfunction in melanoma patients.
Fourcade J; Sun Z; Benallaoua M; Guillaume P; Luescher IF; Sander C; Kirkwood JM; Kuchroo V; Zarour HM
J Exp Med; 2010 Sep; 207(10):2175-86. PubMed ID: 20819923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
